Muggeri, Alejandro
Vago, Miguel
Pérez, Sebastián
Rubio, Marcelo
González, Cecilia
Magariños, Cristian
Rosenberg, Mónica
Costa, Fernando http://orcid.org/0000-0002-8809-4915
Pérez-Lloret, Santiago
Clinical trials referenced in this document:
Documents that mention this clinical trial
A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions
https://doi.org/10.1007/s40268-017-0199-3
Article History
First Online: 29 July 2017
Compliance with Ethical Standards
:
: This study was funded by Monte Verde S.A.
: Miguel Vago, Fernando Costa, Mónica Rosenberg, Sebastián Pérez, Marcelo Rubio, Cristian Magariños and Cecilia González are employed by Laboratorios Raffo S.A. Alejandro Muggeri and Santiago Pérez Lloret have received research honoraria from FLENI-mrc/Centralab CR, the CRO (Contract Research Organization) hired by the sponsor to conduct this study.
: All procedures performed in this study were in accordance with the ethical standards of the Institutional Review and Ethics Committee, GCP, and the 1964 Helsinki declaration and its later amendments.
: Informed consent was obtained from all individual participants included in this study.